Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
12.79
+0.81 (6.76%)
At close: Feb 26, 2026, 4:00 PM EST
13.04
+0.25 (1.95%)
After-hours: Feb 26, 2026, 7:42 PM EST
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $458.67 million as of February 26, 2026. Its market cap has increased by 0.74% in one year.
Market Cap
458.67M
Enterprise Value
213.90M
1-Year Change
0.74%
Ranking
Category
Stock Price
$12.79
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $458.67M, an increase of 82.73%. That is a compound annual growth rate of 14.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 429.62M | 16.54% |
| Dec 31, 2025 | 368.66M | -39.78% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
| Oct 29, 2021 | 251.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verastem | 449.97M |
| PepGen | 439.99M |
| Tectonic Therapeutic | 432.53M |
| REGENXBIO | 431.81M |
| Niagen Bioscience | 426.88M |
| Enanta Pharmaceuticals | 424.84M |
| Upstream Bio | 418.26M |
| LENZ Therapeutics | 413.65M |